Please join our small group of CEOs for a live video session with Dr. Scott Gottlieb to discuss the evolving COVID-19 landscape. The conversation will be hosted as an off-the-record, interactive discussion where you will have the opportunity to listen to Dr. Gottlieb’s expert insights and ask him questions directly.
Tuesday, November 22
1:00 p.m. EDT
RSVP to confirm your attendance. Invitation is non-transferable.
Speakers
Scott Gottlieb is a physician and served as the 23rd Commissioner of the U.S. Food and Drug Administration. Dr. Gottlieb’s work focuses on advancing public health through developing and implementing innovative approaches to improving medical outcomes, reshaping healthcare delivery, and expanding consumer choice and safety. He serves on the boards of Pfizer Inc. and Illumina, Inc., is a resident fellow at the American Enterprise Institute and a partner at the venture capital firm New Enterprise Associates.
Dr. Gottlieb is an aggressive advocate for advancing the health of patients, promoting healthcare access, and driving innovation. The agency’s historic and prolific advances in new policy distinguished his tenure as the FDA’s commissioner, in addition to a record-setting number of approvals of novel drugs, medical devices, and generic medicines. Under his leadership, the FDA advanced new frameworks for the modern and safe and effective oversight of gene therapies, cell based regenerative medicines, targeted drugs, and digital health devices. The FDA implemented new reforms to standardize drug reviews and make historic improvements of post market data collection and the use of real-world evidence. They promoted policies to reduce death and disease from tobacco, improve food safety, and aggressively confront addiction crises.
Previously, Dr. Gottlieb served as the FDA’s Deputy Commissioner for Medical and Scientific Affairs and before that, as a Senior Adviser to the Administrator of the Centers for Medicare and Medicaid Services, where he helped advance policies to improve healthcare quality and promote the effective use of new medical technologies. Dr. Gottlieb is widely published in leading medical journals and periodicals, including The Wall Street Journal, The New York Times, and The Washington Post. He has held editorial positions on the British Medical Journal and the Journal of the American Medical Association and is a regular contributor to CNBC. Fortune Magazine recognized him as one of the “World’s 50 Greatest Leaders” in 2018 and again in 2019. In 2018, 2019 and then again in 2020 Modern Healthcare named Dr. Gottlieb the “Most Influential Physician Executive and Leaders” in its annual survey of 50 physician executives, and Time magazine named him one of its “50 People Transforming Healthcare in 2018.” Dr. Gottlieb is also the author of New York Times Bestseller Uncontrolled Spread: Why COVID-19 Crushed Us and How We Can Defeat the Next Pandemic.
Dr. Gottlieb was a practicing hospitalist, and he is an elected member of the National Academy of Medicine. He lives in Westport, Connecticut with his wife and three daughters.
Lynn Martin is President of NYSE Group, which includes the New York Stock Exchange, the world’s largest stock market.
Martin is the 68th President of the New York Stock Exchange and the second woman to lead the exchange in its 230-year history. The NYSE, the premier venue for capital raising, is the listing home to 2,400 of the world’s most influential and innovative companies.
In addition to the exchange, NYSE Group includes four fully electronic equity markets, including NYSE Arca, the industry leader in ETFs, and two options exchanges.
Martin is also Chair of Fixed Income & Data Services at Intercontinental Exchange, Inc. (NYSE: ICE), the parent of NYSE Group. Most recently, she was President of that business, responsible for ICE Bonds execution venues, securities pricing and analytics, reference data, indices, desktop solutions, consolidated feeds and connectivity services that cover all major asset classes.
She previously served as President of ICE Data Services, COO of ICE Clear U.S., and in a number of leadership roles including CEO of NYSE Liffe U.S. and CEO of New York Portfolio Clearing. Martin began her career at IBM in its Global Services organization.
Martin holds a BS in Computer Science from Manhattan College and an MA in Statistics from Columbia University. She currently sits on the Board of Directors of the Partnership for New York City and the Inner-City Scholarship Fund. Martin also serves on the Manhattan College Board of Trustees as well as the Advisory Board of the School of Science and is a member of the Phi Beta Kappa National Honor Society.